Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Practical guide to quantification of hepatic iron with MRI.

Henninger B, Alustiza J, Garbowski M, Gandon Y.

Eur Radiol. 2020 Jan;30(1):383-393. doi: 10.1007/s00330-019-06380-9. Epub 2019 Aug 7.

2.

Atherosclerosis is aggravated by iron overload and ameliorated by dietary and pharmacological iron restriction.

Vinchi F, Porto G, Simmelbauer A, Altamura S, Passos ST, Garbowski M, Silva AMN, Spaich S, Seide SE, Sparla R, Hentze MW, Muckenthaler MU.

Eur Heart J. 2019 Mar 20. pii: ehz112. doi: 10.1093/eurheartj/ehz112. [Epub ahead of print]

PMID:
30903157
3.

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study.

Cappellini MD, Porter J, Origa R, Forni GL, Voskaridou E, Galactéros F, Taher AT, Arlet JB, Ribeil JA, Garbowski M, Graziadei G, Brouzes C, Semeraro M, Laadem A, Miteva D, Zou J, Sung V, Zinger T, Attie KM, Hermine O.

Haematologica. 2019 Mar;104(3):477-484. doi: 10.3324/haematol.2018.198887. Epub 2018 Oct 18.

4.

A Technique of "Chimney Nellix" for the Management of Type 1a Endoleak After EVAR.

Joseph SZ, Kwok CHR, Hockley JA, Garbowski MW, Ferguson J, Samuelson S, Jansen SJ.

J Vasc Interv Radiol. 2018 May;29(5):623-627. doi: 10.1016/j.jvir.2017.10.022.

PMID:
29685659
5.

Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.

Sellar RS, Gale RE, Khwaja A, Garbowski M, Loddo M, Stoeber K, Williams GH, Linch DC.

Br J Haematol. 2018 May;181(4):486-494. doi: 10.1111/bjh.15211. Epub 2018 Apr 20.

PMID:
29676467
6.

Interaction of Transfusion and Iron Chelation in Thalassemias.

Porter JB, Garbowski MW.

Hematol Oncol Clin North Am. 2018 Apr;32(2):247-259. doi: 10.1016/j.hoc.2017.11.010. Review.

PMID:
29458730
7.

Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.

Vlachodimitropoulou E, Chen YL, Garbowski M, Koonyosying P, Psaila B, Sola-Visner M, Cooper N, Hider R, Porter J.

Blood. 2017 Oct 26;130(17):1923-1933. doi: 10.1182/blood-2016-10-740241. Epub 2017 Sep 1.

8.

Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrin.

Garbowski MW, Evans P, Vlachodimitropoulou E, Hider R, Porter JB.

Haematologica. 2017 Oct;102(10):1640-1649. doi: 10.3324/haematol.2017.170605. Epub 2017 Jun 22.

9.

Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.

Garbowski MW, Ma Y, Fucharoen S, Srichairatanakool S, Hider R, Porter JB.

Transl Res. 2016 Nov;177:19-30.e5. doi: 10.1016/j.trsl.2016.05.005. Epub 2016 Jun 7.

10.

Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease.

Mwipatayi BP, Sharma S, Daneshmand A, Thomas SD, Vijayan V, Altaf N, Garbowski M, Jackson M; COBEST co-investigators.

J Vasc Surg. 2016 Jul;64(1):83-94.e1. doi: 10.1016/j.jvs.2016.02.064. Epub 2016 Apr 28.

11.

Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.

Vlachodimitropoulou Koumoutsea E, Garbowski M, Porter J.

Br J Haematol. 2015 Sep;170(6):874-83. doi: 10.1111/bjh.13512. Epub 2015 Jun 1.

PMID:
26033030
12.

Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.

Porter JB, Walter PB, Neumayr LD, Evans P, Bansal S, Garbowski M, Weyhmiller MG, Harmatz PR, Wood JC, Miller JL, Byrnes C, Weiss G, Seifert M, Grosse R, Grabowski D, Schmidt A, Fischer R, Nielsen P, Niemeyer C, Vichinsky E.

Br J Haematol. 2014 Dec;167(5):692-6. doi: 10.1111/bjh.13081. Epub 2014 Sep 11.

13.

The pathophysiology of transfusional iron overload.

Porter JB, Garbowski M.

Hematol Oncol Clin North Am. 2014 Aug;28(4):683-701, vi. doi: 10.1016/j.hoc.2014.04.003. Review.

PMID:
25064708
14.

Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan.

Garbowski MW, Carpenter JP, Smith G, Roughton M, Alam MH, He T, Pennell DJ, Porter JB.

J Cardiovasc Magn Reson. 2014 Jun 10;16:40. doi: 10.1186/1532-429X-16-40.

15.

Consequences and management of iron overload in sickle cell disease.

Porter J, Garbowski M.

Hematology Am Soc Hematol Educ Program. 2013;2013:447-56. doi: 10.1182/asheducation-2013.1.447. Review.

PMID:
24319218
16.

Images in cardiovascular medicine. Superior vena cava occlusion by cardiovascular magnetic resonance.

Hasleton J, Pasquale F, Garbowski M, Walker MJ, Porter JB, Moon JC.

Circulation. 2010 Aug 24;122(8):853. doi: 10.1161/CIRCULATIONAHA.110.948471. No abstract available.

PMID:
20733115
17.

Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload.

Carpenter JP, Alpendurada F, Deac M, Maceira A, Garbowski M, Kirk P, Walker JM, Porter JB, Shah F, Banya W, He T, Smith GC, Pennell DJ.

J Cardiovasc Magn Reson. 2010 Apr 23;12:24. doi: 10.1186/1532-429X-12-24.

18.

Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.

Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K.

J Vasc Surg. 2008 Feb;47(2):461-9. Epub 2007 Oct 22. Review.

19.
20.

Digital embolization due to partially uncovered left subclavian artery post TEVAR: management with amplatzer vascular plug occlusion.

Chaudhuri A, Tibballs J, Nadkarni S, Garbowski M.

J Endovasc Ther. 2007 Apr;14(2):257-9.

PMID:
17484538

Supplemental Content

Loading ...
Support Center